{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:09:07Z","timestamp":1792814947067,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2023CXQD058"],"award-info":[{"award-number":["2023CXQD058"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009994","name":"Excellent Youth Foundation of Jiangsu Scientific Committee","doi-asserted-by":"publisher","award":["2022JJ10092"],"award-info":[{"award-number":["2022JJ10092"]}],"id":[{"id":"10.13039\/501100009994","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272910"],"award-info":[{"award-number":["82272910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473229"],"award-info":[{"award-number":["82473229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073321"],"award-info":[{"award-number":["82073321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172878"],"award-info":[{"award-number":["82172878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373435"],"award-info":[{"award-number":["82373435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["YWB0013"],"award-info":[{"award-number":["YWB0013"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.celrep.2025.115545","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:26:37Z","timestamp":1744259197000},"page":"115545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy"],"prefix":"10.1016","volume":"44","author":[{"given":"Zhuo","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xurui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liefu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-6005","authenticated-orcid":false,"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.115545_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA. Cancer. J. Clin."},{"key":"10.1016\/j.celrep.2025.115545_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskjot","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.celrep.2025.115545_bib3","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.celrep.2025.115545_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41585-019-0208-0","article-title":"Molecular and histopathology directed therapy for advanced bladder cancer","volume":"16","author":"Alifrangis","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.celrep.2025.115545_bib5","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2025.115545_bib6","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1200\/JCO.19.01140","article-title":"Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1\/Programmed Death Ligand 1 Therapy","volume":"37","author":"Rosenberg","year":"2019","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2025.115545_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(19)31774-X","article-title":"Antibody-drug conjugates for cancer","volume":"394","author":"Chau","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2025.115545_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12935-019-0824-z","article-title":"Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients","volume":"19","author":"Deng","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.celrep.2025.115545_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-015-0144-7","article-title":"Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer","volume":"34","author":"Nishiwada","year":"2015","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.115545_bib10","first-page":"183","article-title":"Expression and clinical significance of Nectin-4 in hepatocellular carcinoma","volume":"9","author":"Ma","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.celrep.2025.115545_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/PAI.0000000000000938","article-title":"Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes","volume":"29","author":"Hoffman-Censits","year":"2021","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.celrep.2025.115545_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155390","article-title":"Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma","volume":"21","author":"Tomiyama","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2025.115545_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1158\/1535-7163.MCT-21-0846","article-title":"The Anti-Nectin 4: A Promising Tumor Cells Target. A Systematic Review","volume":"21","author":"Bouleftour","year":"2022","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.celrep.2025.115545_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11912-023-01360-1","article-title":"Nectin-4: a Tumor Cell Target and Status of Inhibitor Development","volume":"25","author":"Bouleftour","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.celrep.2025.115545_bib15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1200\/JCO.19.02044","article-title":"EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With\u00a0Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma","volume":"38","author":"Rosenberg","year":"2020","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2025.115545_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41585-020-00394-5","article-title":"The biology and rationale of targeting nectin-4 in urothelial carcinoma","volume":"18","author":"Heath","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.celrep.2025.115545_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annonc.2023.09.3114","article-title":"The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma","volume":"35","author":"McGregor","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.celrep.2025.115545_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-019-01241-7","article-title":"Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma","volume":"80","author":"Hanna","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.celrep.2025.115545_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer","volume":"390","author":"Powles","year":"2024","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.115545_bib20","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1158\/1078-0432.CCR-22-1764","article-title":"Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance","volume":"29","author":"Klumper","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.115545_bib21","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1158\/1078-0432.CCR-20-4175","article-title":"Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin","volume":"27","author":"Chu","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.115545_bib22","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1200\/JCO.23.01983","article-title":"NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer","volume":"42","author":"Kl\u00fcmper","year":"2024","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2025.115545_bib23","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/aje\/kwh161","article-title":"Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults","volume":"159","author":"Coughlin","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.celrep.2025.115545_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","article-title":"Fasting serum glucose level and cancer risk in Korean men and women","volume":"293","author":"Jee","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2025.115545_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/07853890902729778","article-title":"Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan","volume":"41","author":"Tseng","year":"2009","journal-title":"Ann. Med."},{"key":"10.1016\/j.celrep.2025.115545_bib26","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/dc10-1068","article-title":"Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study","volume":"34","author":"Lewis","year":"2011","journal-title":"Diabetes. Care."},{"key":"10.1016\/j.celrep.2025.115545_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","article-title":"Metabolic phenotype of bladder cancer","volume":"45","author":"Massari","year":"2016","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.celrep.2025.115545_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-8587(23)00344-3","article-title":"Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants","volume":"12","author":"Jenkins","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.celrep.2025.115545_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11626-017-0217-3","article-title":"Laminar shear stress inhibits high glucose-induced migration and invasion in human bladder cancer cells","volume":"54","author":"Lee","year":"2018","journal-title":"In\u00a0Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.celrep.2025.115545_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2025.115545_bib31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115545_bib32","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.tem.2022.07.004","article-title":"Understanding lactate sensing and signalling","volume":"33","author":"Certo","year":"2022","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.celrep.2025.115545_bib33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.celrep.2025.115545_bib34","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.7150\/ijbs.91492","article-title":"Histone lactylation: from tumor lactate metabolism to epigenetic regulation","volume":"20","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.celrep.2025.115545_bib35","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","article-title":"Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis","volume":"187","author":"Zong","year":"2024","journal-title":"Cellule"},{"key":"10.1016\/j.celrep.2025.115545_bib36","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s12276-023-00997-z","article-title":"The YTHDC1\/GLUT3\/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression","volume":"55","author":"Yan","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celrep.2025.115545_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1172\/JCI118754","article-title":"Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals","volume":"98","author":"Avogaro","year":"1996","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.celrep.2025.115545_bib38","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1172\/JCI114935","article-title":"Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus","volume":"86","author":"Kelley","year":"1990","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.celrep.2025.115545_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010538","article-title":"Quantitative metabolomics by H-NMR and LC-MS\/MS confirms altered metabolic pathways in diabetes","volume":"5","author":"Lanza","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2025.115545_bib40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1172\/JCI2415","article-title":"Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus","volume":"102","author":"Meyer","year":"1998","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.celrep.2025.115545_bib41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1186\/s12967-023-04403-0","article-title":"Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis","volume":"21","author":"Duan","year":"2023","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.celrep.2025.115545_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112033","article-title":"Numb\/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation","volume":"42","author":"He","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.115545_bib43","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1080\/15548627.2021.1974175","article-title":"m(6)A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin","volume":"18","author":"Liang","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.celrep.2025.115545_bib44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.115545_bib45","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.euo.2021.11.005","article-title":"TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells","volume":"5","author":"Chou","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.celrep.2025.115545_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The potential role of RNA N6-methyladenosine in Cancer progression","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2025.115545_bib47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13046-022-02460-9","article-title":"YTHDC1 is downregulated by the YY1\/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway","volume":"41","author":"Li","year":"2022","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.115545_bib48","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-methyladenosine and its role in cancer","volume":"18","author":"He","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2025.115545_bib49","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31311","article-title":"YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs","volume":"6","author":"Roundtree","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2025.115545_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032262","article-title":"JunD\/AP-1-mediated gene expression promotes lymphocyte growth dependent on interleukin-7 signal transduction","volume":"7","author":"Ruppert","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2025.115545_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2025.115545_bib52","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1158\/0008-5472.CAN-20-4107","article-title":"The Emerging Roles of RNA m(6)A Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance","volume":"81","author":"Lan","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.115545_bib53","article-title":"The Potential Roles of RNA N6-Methyladenosine in Urological Tumors","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.celrep.2025.115545_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","article-title":"The role of m(6)A RNA methylation in human cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2025.115545_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13404","article-title":"YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer","volume":"56","author":"Su","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.celrep.2025.115545_bib56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molcel.2020.06.017","article-title":"METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation","volume":"79","author":"Zhang","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.115545_bib57","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood.2021011707","article-title":"A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication","volume":"138","author":"Sheng","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.115545_bib58","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/s41418-021-00804-0","article-title":"YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect","volume":"28","author":"Hou","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2025.115545_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg4993","article-title":"ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation","volume":"9","author":"Jia","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2025.115545_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41418-021-00841-9","article-title":"Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis","volume":"29","author":"Yang","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2025.115545_bib61","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.cmet.2023.07.005","article-title":"The diapause-like colorectal cancer cells induced by SMC4 attenuation are characterized by low proliferation and chemotherapy insensitivity","volume":"35","author":"Sun","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2025.115545_bib62","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.115545_bib63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2025.115545_bib64","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/onc.2008.120","article-title":"Multiple facets of junD gene expression are atypical among AP-1 family members","volume":"27","author":"Hernandez","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2025.115545_bib65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2019.02.005","article-title":"Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells","volume":"448","author":"Elliott","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.celrep.2025.115545_bib66","article-title":"Long Non-coding RNA BTG3-7:1 and JUND Co-regulate C21ORF91 to Promote Triple-Negative Breast Cancer Progress","volume":"7","author":"Dan","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.celrep.2025.115545_bib67","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124985","article-title":"JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer","volume":"6","author":"Ruiz","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2025.115545_bib68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jb\/mvaa027","article-title":"JUND-dependent up-regulation of HMOX1 is associated with cisplatin resistance in muscle-invasive bladder cancer","volume":"168","author":"Peng","year":"2020","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.celrep.2025.115545_bib69","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cellsig.2009.12.008","article-title":"AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise?","volume":"22","author":"Shaulian","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.celrep.2025.115545_bib70","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2147\/OTT.S374908","article-title":"Role of the JNK Pathway in Bladder Cancer","volume":"15","author":"Lee","year":"2022","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.celrep.2025.115545_bib71","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S1097-2765(03)00203-X","article-title":"JunD mediates survival signaling by the JNK signal transduction pathway","volume":"11","author":"Lamb","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.115545_bib72","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1139\/cjpp-2021-0577","article-title":"Anisomycin inhibits angiogenesis, growth, and survival of triple-negative breast cancer through mitochondrial dysfunction, AMPK activation, and mTOR inhibition","volume":"100","author":"Yang","year":"2022","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.celrep.2025.115545_bib73","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.7150\/jca.83355","article-title":"Anisomycin has the potential to induce human ovarian cancer stem cell ferroptosis by influencing glutathione metabolism and autophagy signal transduction pathways","volume":"14","author":"Xiong","year":"2023","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.celrep.2025.115545_bib74","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bbrc.2016.05.139","article-title":"Anisomycin-induced GATA-6 degradation accompanying a decrease of proliferation of colorectal cancer cell","volume":"478","author":"Ushijima","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2025.115545_bib75","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/fcp.12641","article-title":"Anisomycin sensitizes non-small-cell lung cancer cells to chemotherapeutic agents and epidermal growth factor receptor inhibitor via suppressing PI3K\/Akt\/mTOR","volume":"35","author":"Tan","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.celrep.2025.115545_bib76","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1158\/0008-5472.CAN-12-4560","article-title":"TR3 modulates platinum resistance in ovarian cancer","volume":"73","author":"Wilson","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2025.115545_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102826","article-title":"WBP2 restrains the lysosomal degradation of GPX4 to inhibit ferroptosis in cisplatin-induced acute kidney injury","volume":"65","author":"Deng","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.celrep.2025.115545_bib78","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/diab.44.1.104","article-title":"Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice","volume":"44","author":"Davalli","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.celrep.2025.115545_bib79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines","volume":"85","author":"Alfred Witjes","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.celrep.2025.115545_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216606","article-title":"Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer","volume":"585","author":"Fukushima","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.celrep.2025.115545_bib81","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.4596","article-title":"Study EV-104: Phase 1 study of intravesical enfortumab vedotin for treatment of patients with non-muscle invasive bladder cancer (NMIBC)-Trial in progress","volume":"41","author":"Kamat","year":"2023","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2025.115545_bib82","doi-asserted-by":"crossref","first-page":"S507","DOI":"10.1016\/S0302-2838(22)00414-6","article-title":"Study EV-104: Phase 1 study of intravesical enfortumab vedotin for treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC) (Trial in Progress)","volume":"81","author":"Kamat","year":"2022","journal-title":"Eur. Urol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472500316X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472500316X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:19:40Z","timestamp":1768339180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221112472500316X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S221112472500316X"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115545","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115545"}}